Stefan K. Barta

Sep 4, 2024 | targetedonc.com | Stefan K. Barta

Stefan Barta, MD, associate professor of clinical medicine, director, T-cell lymphoma program, University of Pennsylvania Department of Medicine, emphasizes the heterogeneity of T-cell lymphoma, highlighting that a one-size-fits-all approach is ineffective and emphasizing the need for tailored treatment approaches.

May 20, 2024 | mdpi.com | Colin Thomas |Verónica Alzate Carvajal |Stefan K. Barta

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

May 20, 2024 | mdpi.com | Colin Thomas |Verónica Alzate Carvajal |Stefan K. Barta

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Aug 31, 2023 | onlinelibrary.wiley.com | Montreh Tavakkoli |Stefan K. Barta

1 INTRODUCTION Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma. It commonly presents with rapidly enlarging, usually painless lymphadenopathy and B symptoms.